300110 华仁药业
已收盘 02-05 15:00:00
资讯
新帖
简况
华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户
证券之星 · 02-04 20:51
华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户
股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元
证券之星 · 02-02
股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元
华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元
证券之星 · 01-30
华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元
华仁药业:公司暂无相关规划
证券之星 · 01-27
华仁药业:公司暂无相关规划
股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%
证券之星 · 01-26
股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%
华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%
证券之星 · 01-23
华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%
华仁药业:截至2026年1月9日股东户数约3.98万户
证券之星 · 01-14
华仁药业:截至2026年1月9日股东户数约3.98万户
股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元
证券之星 · 01-12
股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元
股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元
证券之星 · 01-05
股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元
每周股票复盘:机构连续两日净买入华仁药业(300110)
证券之星 · 01-03
每周股票复盘:机构连续两日净买入华仁药业(300110)
股市必读:12月30日华仁药业现10笔大宗交易 机构净买入1030.75万元
证券之星 · 2025-12-31
股市必读:12月30日华仁药业现10笔大宗交易 机构净买入1030.75万元
华仁药业:部分生产线已配套使用工业机器人
证券之星 · 2025-12-26
华仁药业:部分生产线已配套使用工业机器人
华仁药业:大股东减持计划正在执行中
证券之星 · 2025-12-24
华仁药业:大股东减持计划正在执行中
华仁药业:此类挂单均属于市场投资者的自主委托行为
证券之星 · 2025-12-24
华仁药业:此类挂单均属于市场投资者的自主委托行为
华仁药业:多索茶碱适用于支气管哮喘
证券之星 · 2025-12-18
华仁药业:多索茶碱适用于支气管哮喘
华仁药业:截至2025年12月10日股东总户数约为3.97万户
证券之星 · 2025-12-16
华仁药业:截至2025年12月10日股东总户数约为3.97万户
华仁药业(300110)披露持股5%以上股东权益变动触及1%整数倍公告,12月11日股价下跌3.27%
证券之星 · 2025-12-11
华仁药业(300110)披露持股5%以上股东权益变动触及1%整数倍公告,12月11日股价下跌3.27%
12月10日华仁药业现6笔大宗交易 机构净买入1936.79万元
证券之星 · 2025-12-10
12月10日华仁药业现6笔大宗交易 机构净买入1936.79万元
华仁药业持股5%以上股东华仁世纪集团减持,持股比例降至6.83%
中金财经 · 2025-12-05
华仁药业持股5%以上股东华仁世纪集团减持,持股比例降至6.83%
华仁药业:截至2025年11月20日股东总户数约为3.94万户
证券之星 · 2025-12-01
华仁药业:截至2025年11月20日股东总户数约为3.94万户
加载更多
公司概况
公司名称:
华仁药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-08-25
主营业务:
华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。
发行价格:
13.99
{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":3.28,"timestamp":1770274992000,"preClose":3.32,"halted":0,"volume":19036900,"delay":0,"changeRate":-0.012,"floatShares":1181000000,"shares":1182000000,"eps":-1.1922,"marketStatus":"已收盘","change":-0.04,"latestTime":"02-05 15:00:00","open":3.31,"high":3.34,"low":3.27,"amount":62886800,"amplitude":0.0211,"askPrice":3.29,"askSize":2964,"bidPrice":3.28,"bidSize":638,"shortable":0,"etf":0,"ttmEps":-1.1922,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770341400000},"marketStatusCode":5,"adr":0,"adjPreClose":3.32,"symbolType":"stock","openAndCloseTimeList":[[1770255000000,1770262200000],[1770267600000,1770274800000]],"highLimit":3.65,"lowLimit":2.99,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":2.9,"roa":"--","roe":"4.11%","epsLYR":-1.1576,"committee":-0.247525,"marketValue":3878000000,"turnoverRate":0.0161,"status":1,"floatMarketCap":3873000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2608614473","title":"华仁药业:截至2026年1月30日,公司股东总户数约为3.89万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608614473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608614473?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:51","pubTimestamp":1770209499,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年1月30日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年1月30日,公司股东总户数约为3.89万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400039424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2608018881","title":"股市必读:华仁药业(300110)预计2025年全年归属净利润亏损3.6亿元至4.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608018881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608018881?lang=zh_cn&edition=full","pubTime":"2026-02-02 05:08","pubTimestamp":1769980097,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,华仁药业报收于3.32元,下跌0.6%,换手率1.96%,成交量23.1万手,成交额7667.13万元。来自:华仁药业发布2025年度业绩预告,预计归母净利润亏损3.6亿元至4.8亿元,主要因商誉减值及产品售价下降所致,剔除商誉减值因素后预计实现净利润6,000万元至8,000万元。业绩披露要点业绩预告华仁药业发布业绩预告,预计2025年全年归属净利润亏损3.6亿元至4.8亿元。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2607019690","title":"华仁药业:预计2025年全年归属净利润亏损3.6亿元至4.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607019690","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607019690?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:19","pubTimestamp":1769768378,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业发布业绩预告,预计2025年全年归属净利润亏损3.6亿元至4.8亿元。剔除前述商誉减值因素影响后,公司预计 2025 年度实现归属于上市公司股东的净利润 6,000 万元-8,000 万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000034255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2606623784","title":"华仁药业:公司暂无相关规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623784?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:51","pubTimestamp":1769518291,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司是否有意愿向新兴行业AI科技类行业靠拢,看看你们老的一套墨守成规的全输液输水带能在市场立足吗?华仁药业回复:尊敬的投资者,您好!公司暂无相关规划。公司密切关注行业动态和技术变革,致力于通过技术创新推动医药产业升级。公司将聚焦医药主业、深耕行业,加快推进医药制造现代化、智能化、产业化,实现高质量发展,努力为股东提供持续、稳定、合理的投资回报。感谢您的关注和建议!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700039531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2606265446","title":"股市必读:华仁药业(300110)股东户数3.92万户,较上期减少1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265446","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265446?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:25","pubTimestamp":1769369114,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,华仁药业报收于3.38元,上涨1.5%,换手率2.19%,成交量25.88万手,成交额8685.9万元。当日关注点来自交易信息汇总:1月23日主力资金净流入186.78万元,显示主力对个股短期态度偏积极。股本股东变化股东户数变动近日华仁药业披露,截至2026年1月20日公司股东户数为3.92万户,较1月9日减少600.0户,减幅为1.51%。户均持股数量由上期的2.97万股增加至3.02万股,户均持股市值为9.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2605475945","title":"华仁药业(300110)1月20日股东户数3.92万户,较上期减少1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605475945","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605475945?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:41","pubTimestamp":1769161306,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2026年1月20日公司股东户数为3.92万户,较1月9日减少600.0户,减幅为1.51%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至1月20日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月9日至2026年1月20日,华仁药业区间跌幅为0.31%,在此期间股东户数减少600.0户,减幅为1.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2603734615","title":"华仁药业:截至2026年1月9日股东户数约3.98万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603734615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603734615?lang=zh_cn&edition=full","pubTime":"2026-01-14 20:52","pubTimestamp":1768395144,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:新尊敬的董秘 年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年1月9日A股股东人数是多少?谢谢华仁药业回复:尊敬的投资者您好,截至2026年1月9日,公司股东总户数约为3.98万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400039152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2602557136","title":"股市必读:1月9日华仁药业现1笔折价10.09%的大宗交易 合计成交88.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557136?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:33","pubTimestamp":1768156388,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,华仁药业报收于3.27元,上涨0.62%,换手率1.9%,成交量22.49万手,成交额7303.48万元。当日关注点来自交易信息汇总:1月9日主力资金净流入674.14万元,显示主力对华仁药业股票的积极介入。来自交易信息汇总:当日发生一笔折价10.09%的大宗交易,合计成交88.2万元,反映部分股东减持意愿。大宗交易1月9日华仁药业现1笔折价10.09%的大宗交易,合计成交88.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2601024251","title":"股市必读:12月31日华仁药业现3笔大宗交易 机构净买入368.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601024251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601024251?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:55","pubTimestamp":1767560108,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,华仁药业报收于3.15元,上涨0.32%,换手率1.3%,成交量15.39万手,成交额4829.61万元。当日关注点来自交易信息汇总:12月31日主力资金净流出368.65万元,占总成交额7.63%。大宗交易12月31日华仁药业发生3笔大宗交易,机构净买入368.26万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","300110"],"gpt_icon":0},{"id":"2600060551","title":"每周股票复盘:机构连续两日净买入华仁药业(300110)","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600060551?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:35","pubTimestamp":1767382512,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,华仁药业报收于3.15元,较上周的3.21元下跌1.87%。本周,华仁药业12月29日盘中最高价报3.22元。12月30日盘中最低价报3.11元。华仁药业当前最新总市值37.24亿元,在化学制药板块市值排名118/150,在两市A股市值排名4096/5181。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2595714018","title":"股市必读:12月30日华仁药业现10笔大宗交易 机构净买入1030.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595714018","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595714018?lang=zh_cn&edition=full","pubTime":"2025-12-31 03:34","pubTimestamp":1767123253,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,华仁药业报收于3.14元,下跌0.95%,换手率1.72%,成交量20.32万手,成交额6395.3万元。当日关注点来自交易信息汇总:12月30日主力资金净流入558.62万元,显示主力对华仁药业股票的积极介入。来自交易信息汇总:当日发生10笔大宗交易,机构净买入1030.75万元,反映机构投资者的较强买入意愿。大宗交易12月30日华仁药业发生10笔大宗交易,机构净买入1030.75万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100003959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2594299817","title":"华仁药业:部分生产线已配套使用工业机器人","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594299817?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:51","pubTimestamp":1766753494,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的机器人运用在生产线上了吗?华仁药业回复:尊敬的投资者您好,公司部分生产线已配套使用工业机器人,主要用于提升生产自动化水平与效率,相关应用符合智能制造发展方向。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2593723244","title":"华仁药业:大股东减持计划正在执行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2593723244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593723244?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580689,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司的大股东减持计划完成了吗?近期是否还有股东变动计划呢?华仁药业回复:尊敬的投资者您好,公司持股5%以上股东华仁世纪集团有限公司减持计划正在执行中。公司将严格遵循信息披露相关规则,及时、准确、完整地向市场披露股东权益变动的相关情况。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2593472550","title":"华仁药业:此类挂单均属于市场投资者的自主委托行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2593472550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593472550?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:51","pubTimestamp":1766580684,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:解释一下公司这个卖单挂单每天有,2188.4188这样的竞价数量是怎么来的?华仁药业回复:尊敬的投资者您好,此类挂单均属于市场投资者的自主委托行为,公司严格遵守相关法律法规、切实履行信息披露义务,不干预二级市场正常交易。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400037395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2592905783","title":"华仁药业:多索茶碱适用于支气管哮喘","url":"https://stock-news.laohu8.com/highlight/detail?id=2592905783","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592905783?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:51","pubTimestamp":1766062298,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月17日在投资者关系平台上答复投资者关心的问题。投资者提问:公司的多索茶碱不是治疗感冒,为什么董秘说有没冶疗感冒药的药?华仁药业回复:尊敬的投资者您好,公司多索茶碱注射液适用于支气管哮喘、慢性喘息性支气管炎及其他支气管痉挛引起的呼吸困难,属支气管扩张剂,当感冒引发相关特定并发症时,可作为对症治疗药物使用。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800035371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2591984135","title":"华仁药业:截至2025年12月10日股东总户数约为3.97万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2591984135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591984135?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:52","pubTimestamp":1765889526,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年12月10日股东人数是多少?华仁药业回复:尊敬的投资者您好,截至2025年12月10日,公司股东总户数约为3.97万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2590594511","title":"华仁药业(300110)披露持股5%以上股东权益变动触及1%整数倍公告,12月11日股价下跌3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590594511","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590594511?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:58","pubTimestamp":1765447122,"startTime":"0","endTime":"0","summary":"截至2025年12月11日收盘,华仁药业报收于3.25元,较前一交易日下跌3.27%,最新总市值为38.42亿元。公司近日发布公告称,华仁药业股份有限公司于2025年12月10日收到持股5%以上股东华仁世纪集团有限公司的告知函,其于2025年12月8日至12月10日通过集中交易和大宗交易方式累计减持公司股份14,815,900股,占公司总股本的1.25%。本次权益变动后,华仁世纪集团及其一致行动人合计持股比例由6.83%降至5.58%,触及1%整数倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100029471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2590880605","title":"12月10日华仁药业现6笔大宗交易 机构净买入1936.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590880605","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590880605?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:43","pubTimestamp":1765359802,"startTime":"0","endTime":"0","summary":"证券之星消息,12月10日华仁药业发生大宗交易,交易数据如下:近三个月该股共发生6笔大宗交易,合计成交7.43万手,折价成交6笔。该股近期无解禁股上市。截至2025年12月10日收盘,华仁药业(300110)报收于3.36元,下跌0.88%,换手率2.51%,成交量29.67万手,成交额9956.07万元。该股近半年内有股东持股变动,合计净减持2633.23万股,股东增减持明细如下表:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000028221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2589950168","title":"华仁药业持股5%以上股东华仁世纪集团减持,持股比例降至6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589950168","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589950168?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:19","pubTimestamp":1764929991,"startTime":"0","endTime":"0","summary":"中访网数据 华仁药业股份有限公司于2025年12月5日收到持股5%以上股东华仁世纪集团有限公司的权益变动告知函。本次权益变动后,华仁世纪集团及其一致行动人合计持有公司股份比例由7.06%减少至6.83%,变动触及1%的整数倍。此次减持是华仁世纪集团根据其于2025年11月13日披露的减持计划进行的,该计划拟在公告之日起十五个交易日后三个月内,通过集中竞价及大宗交易方式减持不超过公司总股本3%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251205/31847673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2588283727","title":"华仁药业:截至2025年11月20日股东总户数约为3.94万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588283727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588283727?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:48","pubTimestamp":1764593319,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问截止到11月20日的最新股东人数是多少,谢谢!华仁药业回复:尊敬的投资者您好,截至2025年11月20日,公司股东总户数约为3.94万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100033263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770301660243,"stockEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0279},{"period":"3month","weight":-0.0377},{"period":"6month","weight":-0.0621},{"period":"1year","weight":0.0744},{"period":"ytd","weight":0.054}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0236},{"period":"6month","weight":0.1285},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0336}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38900人(较上一季度减少0.77%)","perCapita":"30355股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":" 华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}